New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
09:03 EDTAMGN, PCAR, LULU, BIND, APP, PETM, RGDO, ISCA, NQOn The Fly: Pre-market Movers
HIGHER: PetSmart (PETM), up 16% after activist investor Jana Partners disclosed that it has acquired a 9.9% stake and intends to have talks with PetSmartís board of directors and management regarding a review of strategic alternatives including exploring a sale... American Apparel (APP), up 9.6% after deposed CEO Dov Charney reportedly surrendered his entire stake and voting rights in the retailer to hedge fund Standard General, according to Reuters... International Speedway (ISCA), up 4% after reporting Q2 adjusted EPS and revenue that beat expectations... PACCAR (PCAR), up 4% after research reports said Daimler's (DDAIY) truck chief claimed to have been told that Volkswagen (VLKAY) wants to take over the truck maker, though a spokesman for Volkswagen told Dow Jones that there is "no truth" to the reports that it is planning an acquisition bid... lululemon (LULU), up 3.7% after The Wall Street Journal reported last night, citing people familiar with the situation, that the company's founder has been talking to private equity firms through advisers about taking the company private. LOWER: Regado Biosciences (RGDO), down 54% after announcing that the Data Safety Monitoring Board has initiated an unplanned review of data from the REGULATE-PCI trial and the stock was downgraded to Underperform from Outperform at Wedbush... NQ Mobile (NQ), down 21.5% after reporting that its auditor, PwC, has requested to expand the scope of its 2013 audit work and that the audit committee chair is stepping down from the board... BIND Therapeutics (BIND), down 13% after announcing Amgen (AMGN) will not be exercising its development option under the companies' collaborative research program.
News For PETM;LULU;NQ;APP;PCAR;ISCA;BIND;AMGN;RGDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
August 27, 2015
17:24 EDTAMGNFDA approves Repatha
The U.S. Food and Drug Administration approved Repatha injection for some patients who are unable to get their low-density lipoprotein cholesterol under control with current treatment options. Repatha is marketed by Amgen Inc., of Thousand Oaks, Calif. Reference Link
16:28 EDTNQOn The Fly: Top stock stories for Thursday
Subscribe for More Information
09:26 EDTNQOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTAMGNFDA PDUFA Date for Amgen's Repatha is August 27, 2015
07:56 EDTLULULululemon September weekly volatility elevated into Q2 and outlook
Lululemon 9/11/15 weekly call option implied volatility is at 66, September is at 61, October is at 48; compared to its 52-week range of 25 to 63, suggesting large near term price movement into the expected release of Q2 results on September 10.
07:52 EDTLULUBarclays would be a buyer of lululemon into the Q2 report
Barclays analyst Matt McClintock believes lululemon will report meaningful upside to his 7.7% total comp estimate when it reports Q2 earnings on September 10. Channel checks suggest a strong consumer response to new tops introduced in Q2 with stock outs above 50%, promising Google search activity, and momentum in men's. McClintock believes his earnings estimates will prove conservative and is a buyer into the report. Barclays' rates lululemon an Overweight with an $85 price target on shares.
August 26, 2015
20:03 EDTNQOn The Fly: After Hours Movers
Subscribe for More Information
18:33 EDTNQNQ Mobile up 56% to $4.75 after entering agreement to sell FL Mobile subsidiary
17:10 EDTNQNQ Mobile enters agreement to sell FL Mobile subsidiary
Subscribe for More Information
17:06 EDTNQNQ Mobile sees Q3 revenue $110.0M-$112.0M, two estimates $118.50M
Subscribe for More Information
17:05 EDTNQNQ Mobile sees FY15 revenue $455.0M-$460.0M, two estimates $449.70M
Subscribe for More Information
17:03 EDTNQNQ Mobile reports Q2 non-GAAP EPS 8c, two estimates 5c
Reports Q2 revenue $102.1M, two estimates $102.00M.
17:00 EDTNQNQ Mobile enters into a binding agreement to sell NationSky
NQ Mobile has entered into legally binding share purchase agreements, which provide for the sale of all of NQ Mobile's interest in the NationSky business, including the entire interest in Beijing NationSky Network Technology, to Hou Shuli, a founder and senior management member of Beijing NationSky, for an aggregate consideration of $80M cash. The NationSky business provides device agnostic managed mobile services, mobile device management services and other mobile SaaS offerings to enterprises. The company's board of directors and audit committee approved the NationSky Agreements and the NationSky Divestment. The NationSky Divestment is expected to close within 60 days.
10:00 EDTPCAROn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:44 EDTPCARPACCAR upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
06:02 EDTAMGNAmgen implied volatility of 41 at upper end of index
August 25, 2015
14:50 EDTNQNQ Mobile volatility elevated into Q2 and outlook
NQ Mobile August weekly call option implied volatility is at 183, September is at 129, October is at 104; compared to its 52-week range of 64 to 200, suggesting large near term price movement into the expected release of Q2 results on August 27.
09:16 EDTAMGNAmgen to present Repatha data analysis at ESC Congress 2015
Subscribe for More Information
09:02 EDTAMGNAmgen submits NDA for hyperparathyroidism treatment
Subscribe for More Information
August 24, 2015
13:36 EDTAMGNBiotech correction presents some opportunities, says RBC Capital
RBC Capital analyst Michael Yee said he won't try to pick the short-term bottom in biotech, but contends that any macro weakness in China shouldn't have any major impact to financials or fundamentals for the sector given their minimal exposure there. If the market continues to be volatile, Yee recommends a focus on names with defensive characteristics, such as higher margins and free cash flow yield, naming Amgen (AMGN), Celgene (CELG) and Gilead (GILD) as some examples. The analyst adds that he likes Vertex (VRTX) on the pullback for "more aggressive" growth investors. Yee has Outperform ratings on all of the stocks mentioned above.
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use